<?xml version="1.0" encoding="UTF-8" ?>
<article>
<title><b>Ethnopharmacology to modern medicine: assessing the efficacy of stonebreaker (<i>Phyllanthus amarus</i>) in traditional and contemporary treatment of renal and gastric disorders</b></title>
<authors>M. S. Afariogun</authors>
<keywords>Bioactive compounds, ethnopharmacology, hepatoprotective, herbal medicine, nephroprotective</keywords>
<pages>49-57</pages>
<issue_number>9 (3)</issue_number>
<issue_period>July  2025 </issue_period>
<abstract><i>Phyllanthus amarus</i> (Stonebreaker) has been utilized for centuries across diverse traditional medicine systems, including Ayurveda, African herbal medicine, and South American folk remedies, for the treatment of renal and gastric disorders. This review critically evaluates its ethnopharmacological applications, phytochemical composition, pharmacological mechanisms, clinical efficacy, and safety profile. Clinical studies support its efficacy in managing kidney stones (demonstrating a 58% stone-free rate in recent trials), liver disorders (with 38% HBsAg reduction in hepatitis B patients), and metabolic conditions, though concerns regarding dose-dependent nephrotoxicity warrant further toxicological evaluation. Emerging applications in nanotechnology-enhanced drug delivery, precision medicine, and synergistic combination therapies present promising avenues for future research. By synthesizing traditional knowledge with contemporary scientific validation, this review highlights the potential of <i>P. amarus</i> as a bridge between ethnopharmacology and evidence-based medicine, while identifying critical gaps in standardization, long-term safety assessment, and clinical translation that require further investigation.</abstract>
</article>
